Official Title
Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial
Phase
Phase 2Lead Sponsor
Karolinska InstituteStudy Type
InterventionalStatus
TerminatedIndication/Condition
Pain Cerebral Palsy, SpasticIntervention/Treatment
rimabotulinumtoxinB sodium chloride ...Study Participants
16The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.
Intramuscular injections in spastic muscle with regional muscle-related pain
Intramuscular injections in spastic muscle with regional muscle-related pain
Intramuscular injections of Botulinum toxin-A in spastic muscles with regional muscle-related pain
Intramuscular injections of normal saline solution in spastic muscles with regional muscle-related pain
Inclusion Criteria: Age ≥ 18 years. Spastic Cerebral Palsy. Chronic pain, related to spastic muscle. Chronic pain defined as: 1)Recurring regional pain for at least three months AND 2)Pain intensity on average for the last 24 hours ≥3 on Numerical Rating Scale. Signed Informed consent. Exclusion Criteria: Allergy/hypersensitivity to Dysport® or any of its components. Pregnancy. Women who breastfeed their children. Treatment with Botulinum toxin-A within the last five months. If there has been dose changes in any muscle-tone altering medication within two weeks of Visit 1. A clear degenerative cause behind the pain as elucidated by the clinical examination (e.g. history of osteoarthritis). Intellectual disability and/or communication impairment that disable the individual from answering the questionnaires and giving informed consent.